Medical Loss Ratio

Medical Loss Ratio in United States Health Insurance Regulation

The medical loss ratio measures how much of what an insurer collects in premiums, after taxes and regulatory fees, goes back out as payment for members' clinical care and recognised quality improvement, with the remainder left for administration and profit. Since the Affordable Care Act, United States federal law has used it as a floor, so a health insurer whose ratio falls below a set standard must refund the shortfall to the people and employers who paid the premiums. Health economists care about the ratio because it is one of the two components of an insurer's price-cost margin, and because a floor on a ratio changes what an insurer gains from controlling the cost of care. The regulatory calculation also averages three years and adds a credibility adjustment that protects small insurers against chance results.

How an accounting ratio became a spending floor

In insurance accounting a claim paid is a loss to the insurer, so the share of premium paid out in claims is called a loss ratio. Section 2718 of the Public Health Service Act, added by the Affordable Care Act in 2010, requires each issuer of group or individual health insurance to report the ratio of incurred loss, or incurred claims, plus loss adjustment expense to earned premiums, with the share of premium spent on clinical services, on activities that improve health care quality and on all other non-claims costs.

The same section requires an annual rebate to enrolees, on a pro rata basis, beginning not later than 1 January 2011, whenever the share spent on clinical services and quality improvement falls below 85% in the large group market or 80% in the small group and individual markets. A state may set a higher percentage, and the Secretary of Health and Human Services may adjust the individual market standard in a state where 80% might destabilise that market. The rule covers health insurance sold in the fully insured commercial markets, including grandfathered plans.

How the federal ratio is calculated

The detailed rules are in 45 CFR Part 158, which implements section 2718. From 2014 the statute bases the test on three-year averages, and the ratio is calculated separately for each market in each state.

$$MLR_t = \frac{\sum_{k=t-2}^{t} (C_k + Q_k)}{\sum_{k=t-2}^{t} (P_k - T_k)} + CA_t$$

where $MLR_t$ is the medical loss ratio for reporting year $t$, $C_k$ is incurred claims in year $k$, $Q_k$ is expenditure on activities that improve health care quality, $P_k$ is earned premium after the adjustments the regulation specifies for the risk adjustment, risk corridors and reinsurance programmes, $T_k$ is federal and state taxes and licensing and regulatory fees, and $CA_t$ is the credibility adjustment, if any. Under 45 CFR 158.221 the result is rounded to three decimal places.

When the ratio is below the applicable standard, 45 CFR 158.240 sets the rebate for the reporting year as follows.

$$B_t = (m^* - MLR_t) \times (P_t - T_t)$$

where $B_t$ is the total rebate, $m^*$ is the applicable standard (0.85, 0.80 or a higher state figure) and the bracket on the right is adjusted premium for the current reporting year alone. Rebates in the individual market go to the subscriber, while in the group markets they go to the policyholder, usually the employer, under 45 CFR 158.242.

What counts as claims and quality improvement

The ratio depends heavily on where each item of spending is booked. Under 45 CFR 158.140, incurred claims include payments to providers, including under capitation contracts, reserves for claims incurred but not yet reported, and provider bonuses tied to objectively measurable quality standards. Prescription drug rebates are deducted, and whatever a vendor bills above what it pays providers is excluded.

Under 45 CFR 158.150, quality improvement must be designed to improve health quality in objectively measurable ways and be grounded in evidence-based medicine, widely accepted best clinical practice or criteria from recognised professional and quality bodies. Case management and chronic disease management qualify. Activities designed primarily to contain costs, retrospective and concurrent utilisation review, fraud prevention and marketing do not, and under 45 CFR 158.160 they count as non-claims costs. The overhead side of the same accounts, and the several ways of dividing it, is the subject of the administrative cost ratio.

Three-year averaging and the credibility adjustment

Claims in a small pool vary by chance between years, so an insurer that priced its cover correctly could still fall below the floor in an unlucky year, a risk that shrinks as the pool grows under the law of large numbers. The regulation responds with three-year aggregation and a credibility adjustment added to the ratio of a partially credible insurer.

Under 45 CFR 158.230 and 158.231, credibility depends on life-years, defined as total months of coverage divided by 12 and summed over the three years. Experience of 75,000 life-years or more is fully credible and gets no adjustment. Experience of fewer than 1,000 life-years is non-credible, and the insurer is presumed to meet the standard. Between the two, 45 CFR 158.232 sets the adjustment as a base credibility factor multiplied by a deductible factor, each read from a table with linear interpolation between the listed points.

The deductible factor is 1.000 for an average per-person deductible below USD 2,500, 1.164 at USD 2,500, 1.402 at USD 5,000 and 1.736 at USD 10,000 or more. Since the 2013 reporting year the adjustment has been set to zero when every year in the aggregation had at least 1,000 life-years and the insurer's single-year preliminary ratio was below the standard in each of the three years.

Floors in Medicare Advantage, Part D and Medicaid managed care

Public programmes that pay private plans have their own rules. Under 42 CFR 422.2410, a Medicare Advantage organisation whose ratio for a contract is below 0.85 in a contract year must remit to the Centers for Medicare and Medicaid Services (CMS) the contract's total revenue multiplied by the shortfall. Three consecutive years below 0.85 bar new enrolment, and five lead to termination of the contract. Part D prescription drug sponsors face the same structure under 42 CFR 423.2410.

For Medicaid managed care, 42 CFR 438.8 requires each plan to calculate and report a ratio but leaves the minimum to the state. A state that sets one must set it at 85% or higher, and a remittance is owed only if the state requires it. The Medicaid numerator includes fraud prevention activities, which the commercial rule keeps out of quality improvement.

Incentives created by a ratio floor

A floor on the ratio is a form of margin regulation. Karaca-Mandic and colleagues describe the ratio as one component of the price-cost margin, a traditional gauge of market power, the other being the share of premium spent on administration. Using individual market data for 2001 to 2009, they found that insurers with monopoly power had lower ratios, and concluded that the ratio could serve as a target for regulating market power, though with limited ability to capture differences between products and firms.

The difficulty is that a floor caps the margin as a share of premium, not its level. When the floor binds exactly, the amount left for administration and margin is tied to the amount spent on care.

$$S + N = \frac{1 - m^*}{m^*}\,(C + Q)$$

where $S$ is the insurer's margin, $N$ is non-claims costs other than taxes and fees, and $C$, $Q$ and $m^*$ are as defined above, all for one year. At an 80% floor, each extra dollar of claims and quality spending allows a further 25 cents of administration and margin, since $\frac{0.20}{0.80} = 0.25$, so a constrained insurer gains from higher claims, much as a seller does under percentage cost-plus pricing.

The evidence is consistent with this. Cicala, Lieber and Marone, treating the rule's introduction as a natural experiment, found that medical claims rose nearly one for one with an insurer's distance below the threshold, by 7% in the individual market and 2% in the group market, while premiums were unaffected. Abraham and colleagues found that 44.3% of individual market insurers met the standard in 2010 and 63.2% in 2011, with the largest rises among those furthest below it, through higher claims and lower administrative expenses. McCue and colleagues found that for-profit individual market insurers cut their median administrative cost ratio and operating margin by more than two percentage points each between 2010 and 2011, raising their median medical loss ratio by seven points.

Worked example with a small-group insurer near the 80% floor

The figures are illustrative and describe a hypothetical insurer in one state's small group market, where the standard is 80% and the 2025 reporting year aggregates 2023 to 2025. Adjusted premium means earned premium less taxes and fees after the risk programme adjustments, and the numerator is claims plus quality improvement, both in USD million.

1. Credibility class. The insurer has 6,000 + 6,200 + 6,300 = 18,500 life-years, between 1,000 and 75,000, so its experience is partially credible.

2. Unadjusted ratio. The numerator is 32.6 + 33.0 + 34.6 = 100.2 and the denominator is 40.0 + 42.0 + 45.0 = 127.0.

$$\frac{100.2}{127.0} = 0.7890$$

where the result is the three-year ratio before credibility.

3. Base credibility factor. 18,500 life-years lies between 10,000 (2.6%) and 25,000 (1.6%), so the factor is interpolated.

$$2.6 - \frac{18500 - 10000}{25000 - 10000} \times (2.6 - 1.6) = 2.0333$$

where the result is in percentage points.

4. Deductible factor. The life-year weighted average per-person deductible is USD 3,500, between USD 2,500 (1.164) and USD 5,000 (1.402).

$$1.164 + \frac{3500 - 2500}{5000 - 2500} \times (1.402 - 1.164) = 1.2592$$

where the result is the deductible factor.

5. Adjusted ratio. The adjustment is 2.0333 × 1.2592 = 2.5604 percentage points. The 2023 single-year ratio of 0.815 is above 80%, so the zero-adjustment exception does not apply, and the ratio is 0.7890 + 0.0256 = 0.8146, rounded to 0.815. The insurer meets the standard and owes no rebate. Without the adjustment, the rounded ratio of 0.789 would have required a rebate of $(0.800 - 0.789) \times 45.0 = 0.495$, or USD 495,000.

6. A persistent shortfall. Suppose instead that 2023 claims plus quality improvement were 31.8, a single-year ratio of $\frac{31.8}{40.0} = 0.795$. All three years are now below 80%, so the credibility adjustment is zero. The ratio is $\frac{99.4}{127.0} = 0.7827$, rounded to 0.783, and the rebate is $(0.800 - 0.783) \times 45.0 = 0.765$, or USD 765,000, paid to employer policyholders in proportion to premium.

7. Interpretation. A single-year test on 2025 alone with no credibility adjustment, at $\frac{34.6}{45.0} = 0.769$, would have meant a rebate of $(0.800 - 0.769) \times 45.0 = 1.395$, or USD 1.395 million. Averaging and credibility protect a small pool from one poor year, and the exception stops them shielding a shortfall that recurs.

What the ratio can and cannot show

Robinson, writing before the federal floor existed, argued that the ratio had been interpreted as something it is not, such as a measure of quality or efficiency, and that integration between payers and providers complicates any reading of plan finances. A high ratio can reflect high provider prices, a sicker membership or weak claims control as easily as lean administration, and it says nothing about the health gained from the care purchased. Judging that needs measures of technical efficiency or cost-effectiveness, not a spending share.

Several misreadings recur.

1. Reading the floor as a premium cap. It limits margin and administration as a share of premium, and premiums can rise with claims.
2. Comparing ratios across programmes. Standards, numerators and penalties differ between commercial cover, Medicare Advantage and Medicaid.
3. Ignoring the averaging. A rebate depends on three years of data and on credibility, not on the latest year alone.
4. Reading "loss" as harm to patients. The term comes from the insurer's accounts.

Sources

• Abraham JM, Karaca-Mandic P, Simon K. How has the Affordable Care Act's medical loss ratio regulation affected insurer behavior? Medical Care. 2014;52(4):370-377. https://doi.org/10.1097/MLR.0000000000000091
• Centers for Medicare and Medicaid Services. Medical Loss Ratio. CMS Center for Consumer Information and Insurance Oversight; accessed 26 October 2026. https://www.cms.gov/marketplace/private-health-insurance/medical-loss-ratio
• Cicala S, Lieber EMJ, Marone V. Regulating markups in US health insurance. American Economic Journal: Applied Economics. 2019;11(4):71-104. https://doi.org/10.1257/app.20180011
• Code of Federal Regulations. Title 42, sections 422.2410 and 422.2420 (Medicare Advantage), 423.2410 (Part D) and 438.8 (Medicaid managed care). eCFR, current as at 23 October 2026. https://www.ecfr.gov/current/title-42
• Code of Federal Regulations. Title 45, Part 158: Issuer use of premium revenue: reporting and rebate requirements, sections 158.101, 158.102, 158.140, 158.150, 158.160, 158.210, 158.211, 158.220, 158.221, 158.230, 158.231, 158.232, 158.240 and 158.242. eCFR, current as at 23 October 2026. https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-B/part-158
• Karaca-Mandic P, Abraham JM, Simon K. Is the medical loss ratio a good target measure for regulation in the individual market for health insurance? Health Economics. 2015;24(1):55-74. https://doi.org/10.1002/hec.3002
• McCue M, Hall M, Liu X. Impact of medical loss regulation on the financial performance of health insurers. Health Affairs. 2013;32(9):1546-1551. https://doi.org/10.1377/hlthaff.2012.1316
• Public Health Service Act, section 2718 (42 U.S.C. 300gg-18), Bringing down the cost of health care coverage, as added by the Patient Protection and Affordable Care Act, Pub. L. 111-148, 2010. https://www.law.cornell.edu/uscode/text/42/300gg-18
• Robinson JC. Use and abuse of the medical loss ratio to measure health plan performance. Health Affairs. 1997;16(4):176-187. https://doi.org/10.1377/hlthaff.16.4.176